In this foundational episode, we explore how medical devices are defined and classified by the FDA—a critical first step in navigating the regulatory landscape. Starting with the legal distinction between devices and drugs, we unpack the FDA’s risk-based classification system that categorizes devices into Class I, II, or III based on their potential harm to patients. The discussion delves into how classification affects everything from pre-market submission pathways (like 510(k), De Novo, and PMA) to clinical testing, timelines, and budget planning. Through real-world examples—ranging from dental x-ray holders to implantable prostheses—the episode illustrates the diversity within each risk class and the strategic implications of classification decisions.

Listeners also receive a detailed tour through the regulatory ecosystem that supports d ...